19-41349011-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000660.7(TGFB1):c.356-556T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0618 in 152,106 control chromosomes in the GnomAD database, including 343 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.062   (  343   hom.,  cov: 32) 
Consequence
 TGFB1
NM_000660.7 intron
NM_000660.7 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.217  
Publications
7 publications found 
Genes affected
 TGFB1  (HGNC:11766):  (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016] 
TGFB1 Gene-Disease associations (from GenCC):
- Camurati-Engelmann diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- inflammatory bowel disease, immunodeficiency, and encephalopathyInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- cystic fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0755  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TGFB1 | NM_000660.7 | c.356-556T>C | intron_variant | Intron 1 of 6 | ENST00000221930.6 | NP_000651.3 | ||
| TGFB1 | XM_011527242.3 | c.356-556T>C | intron_variant | Intron 1 of 6 | XP_011525544.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TGFB1 | ENST00000221930.6 | c.356-556T>C | intron_variant | Intron 1 of 6 | 1 | NM_000660.7 | ENSP00000221930.4 | |||
| TGFB1 | ENST00000600196.2 | c.356-556T>C | intron_variant | Intron 1 of 5 | 5 | ENSP00000504008.1 | ||||
| TGFB1 | ENST00000677934.1 | c.356-556T>C | intron_variant | Intron 1 of 4 | ENSP00000504769.1 | 
Frequencies
GnomAD3 genomes  0.0619  AC: 9401AN: 151988Hom.:  341  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
9401
AN: 
151988
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.0618  AC: 9407AN: 152106Hom.:  343  Cov.: 32 AF XY:  0.0596  AC XY: 4430AN XY: 74348 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
9407
AN: 
152106
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
4430
AN XY: 
74348
show subpopulations 
African (AFR) 
 AF: 
AC: 
2556
AN: 
41494
American (AMR) 
 AF: 
AC: 
606
AN: 
15250
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
147
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
7
AN: 
5170
South Asian (SAS) 
 AF: 
AC: 
365
AN: 
4816
European-Finnish (FIN) 
 AF: 
AC: 
327
AN: 
10602
Middle Eastern (MID) 
 AF: 
AC: 
17
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
5250
AN: 
67996
Other (OTH) 
 AF: 
AC: 
104
AN: 
2106
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 447 
 894 
 1341 
 1788 
 2235 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 114 
 228 
 342 
 456 
 570 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
100
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.